Treatment
Intravenous clinical trials
We’re tracking 544 recruiting studies that include Intravenous, each written for real people, not researchers, below.
Recruiting studies
- NCT06826313RecruitingPhase 1
Virus treatment for advanced solid tumors
This trial tests an intravenous virus treatment (VRT106) for people with advanced solid tumors that have stopped responding to standard therapies. The goal is to see if the virus can target and help control the cancer.
Guangzhou, GuangdongAges 18–75 - NCT06830798RecruitingPhase 3
Ravulizumab to prevent delayed graft function after kidney transplant
This study tests an investigational medicine (ravulizumab) given through a vein to see if it can prevent delayed graft function—meaning the new kidney takes longer to start working—after a high-risk kidney transplant. It is for adults on dialysis who are getting a kidney from a donor whose heart stopped or who is considered high-risk.
Phoenix, ArizonaAges 18 years+ - NCT06833788RecruitingPhase 4
Intravenous vs oral iron for anaemia after caesarean: effect on postpartum depression
This study compares two ways of treating low red blood cells (anaemia) after a caesarean delivery: iron given through a vein (IV) versus iron taken by mouth (oral pills). The goal is to see if either method helps prevent or reduce symptoms of postpartum depression, which can be linked to anaemia.
ParisAges 18 years+ - NCT06795022RecruitingPhase 1/Phase 2
Testing AZD9793 for advanced solid tumors with GPC3
This trial is testing a new medicine, AZD9793, for people with advanced or metastatic solid tumors that have a specific marker called GPC3. The goal is to see if AZD9793 can help shrink or control the cancer.
La Jolla, CaliforniaAges 18 years+ - NCT04837885RecruitingPhase 2
Liver-targeted radioactive drug for GI or pancreas NET liver spread
This study tests a way to deliver a radioactive “somatostatin-type” medicine directly into the liver artery to treat liver-dominant spread of neuroendocrine tumors (NETs). It may help shrink or control liver metastases after standard treatment has not worked enough.
BordeauxAges 18 years+ - NCT06789029RecruitingPhase 4
Dexamethasone and numbing medicine for children's spine surgery
This study tests whether giving a common anti-inflammatory medicine (dexamethasone) in a different way or using a different strength of numbing medicine can reduce pain and swelling during and after spine surgery in children. It's for kids aged 11–17 who are having surgery for a curved spine that started without a known cause.
PoznanAges 10–18 - NCT06784791RecruitingPhase 2
Amivantamab before surgery for EGFR-mutant lung cancer
This trial tests a new drug, amivantamab, given before surgery for people with a specific EGFR-mutated lung cancer. It aims to shrink tumors and improve surgical outcomes, and may be combined with standard chemotherapy in some patients.
HasseltAges 18 years+ - NCT06784999RecruitingPhase 4
Pain relief after head and neck reconstructive surgery
This study compares two medicines, sufentanil and methadone, for pain control after head and neck surgery that uses a flap to rebuild tissue. The goal is to find which option works better and has fewer side effects.
Indianapolis, IndianaAges 18–80 - NCT06157502RecruitingPhase 3
Shuxuening with clot-busting treatment for ischemic stroke
This trial tests if adding the herbal injection Shuxuening to standard clot-busting treatment improves recovery for people having an ischemic stroke. It is for adults within 6 hours of symptom onset who are already receiving a clot-dissolving medication.
Beijing, Beijing MunicipalityAges 18–100 - NCT06772623RecruitingPhase 1/Phase 2
Study of telisotuzumab adizutecan plus immunotherapy for advanced lung cancer
This trial tests a new combination treatment for people with advanced non-squamous non-small cell lung cancer who haven't received prior therapy for advanced disease and don't have specific gene changes. The treatment includes an antibody-drug conjugate (telisotuzumab adizutecan) plus an immunotherapy drug (PD-1 checkpoint inhibitor) to see if it helps shrink tumors and improve outcomes.
Phoenix, ArizonaAges 18 years+ - NCT06779890RecruitingPhase 4
Comparing anesthesia types for brain tumor surgery
This trial compares two types of anesthesia (gas vs. IV) during brain tumor surgery to see which one better protects the brain and helps with thinking and memory after the operation.
ThessalonikiAges 18–80 - NCT06781697RecruitingPhase 3
Ketamine and virtual reality for treatment-resistant depression
This trial tests if adding virtual reality to ketamine treatments can help people with depression that hasn't improved with other treatments. You'll receive IV ketamine as prescribed by your doctor and also use a virtual reality headset during sessions.
Toronto, OntarioAges 18 years+ - NCT06750731Recruiting
IV vs. shot vedolizumab for IBD with remote check-ins
This study compares two ways of taking the IBD medicine vedolizumab (injecting under the skin versus through an IV line). You'll use a smartphone app to report your symptoms, so you can participate from home and help doctors learn which option works better.
New Orleans, LouisianaAges 18 years+ - NCT06751238RecruitingPhase 1
Secukinumab for children with psoriatic arthritis
This study tests a drug called secukinumab (given through an IV) in children with juvenile psoriatic arthritis. The goal is to see how well it works and if it's safe over time, for up to 6 years.
Loma Linda, CaliforniaAges 2–17 - NCT05759078RecruitingPhase 4
IV iron treatment after a heart attack for low-iron patients
This trial tests whether giving IV ferric carboxymaltose can lower the risk of death and heart complications after a recent heart attack, and improve quality of life. It is for adults with low iron levels and specific heart/health risk factors identified soon after their heart attack.
Bydgoszcz, Kuyavian-Pomeranian VoivodeshipAges 18–90 - NCT04711200RecruitingPhase 1/Phase 2
Study of special stem cells for severe skin peeling (SJS-TEN)
This early-phase trial tests stem-cell treatment to help people with severe skin reactions called SJS-TEN. It may reduce ongoing skin damage and help recovery when treatment is started soon after symptoms begin.
CréteilAges 18–75 - NCT06736483RecruitingPhase 2
Dexmedetomidine for children’s groin surgery recovery
This trial tests whether adding a sedative called dexmedetomidine to a numbing shot (nerve block) helps children aged 1–7 recover better after groin surgery. The goal is to improve comfort and reduce side effects.
Montpellier, FranceAges 1–7 - NCT05969561Recruiting
Ultrasound-guided nerve block for hip-fracture pain in the ER
This trial tests whether an emergency doctor can safely and effectively place a pain-relieving nerve block in the thigh using ultrasound for people with hip fractures. It may help reduce pain while you are in the emergency department.
Douliu, Yunlin CountyAges 20 years+ - NCT06714006RecruitingPhase 1
Testing safety of PYC-003 for ADPKD
This study is testing a new investigational medicine called PYC-003 for people with autosomal dominant polycystic kidney disease (ADPKD). It is one of the first studies in humans, so the main goal is to see if the medicine is safe and tolerable. The study is for people with a specific genetic cause (PKD1 mutation) and with certain kidney imaging types.
Southport, Gold CoastAges 18–65 - NCT06715306Recruiting
IV vs. Oral Antibiotics for Common Infections
This trial compares starting antibiotics through a vein (IV) to taking them by mouth for common infections like pneumonia, urinary tract infections, or skin infections (cellulitis). The goal is to see if oral antibiotics work just as well without the need for an IV line.
Aabenraa, Southern DenmarkAges 18 years+ - NCT05292001RecruitingPhase 4
Single IV iron dose for anemia after leg or pelvic fractures
This trial tests whether giving a one-time IV iron treatment can improve anemia (low blood count) after surgery for a leg or pelvic fracture. It may help your body make red blood cells faster after blood loss from the injury and operation.
Portland, OregonAges 18–89 - NCT06682988RecruitingPhase 2
New treatment for advanced ovarian cancer
This trial tests a drug called mirvetuximab soravtansine for people with platinum-resistant ovarian, peritoneal, or fallopian tube cancer that has high levels of a protein called folate receptor-alpha (FRα). It is given through a vein (IV) and aims to stop cancer from growing.
Sarasota, FloridaAges 18 years+ - NCT06668571RecruitingPhase 2
Ketamine for treatment-resistant depression
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
Rochester, MinnesotaAges 18–65 - NCT06636656RecruitingPhase 2
Testing a new drug for ulcerative colitis after other treatments failed
This study tests a new medication called BI 3032950 for people with ulcerative colitis who have already tried other advanced treatments (biologics or targeted therapies) that didn't work well enough or caused problems. The goal is to see if the new drug is safe and helps control inflammation in the colon.
Scottsdale, ArizonaAges 18–80
Common questions
- Are there clinical trials studying Intravenous?
- Yes. Clin2 currently lists 544 recruiting studies that include Intravenous, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Intravenous trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Intravenous an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Intravenous or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.